BTIG analyst Justin Zelin reiterated a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $20.00. The company’s ...

In a report released today, Ryan Zimmerman from BTIG maintained a Hold rating on Solventum Corporation (SOLV – Research Report). The company’s ...

BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.

Fintel reports that on March 20, 2025, BTIG initiated coverage of Orchestra BioMed Holdings (NasdaqGM:OBIO) with a Buy recommendation. Analyst Price Forecast Suggests 247.03% Upside As of March 19, ...

Strategy aims to raise $711 million for Bitcoin acquisition and working capital through Series A Preferred Stock offering at ...

Investment analysts at Zacks Research lifted their FY2027 earnings per share (EPS) estimates for Lennar in a research report issued on Wednesday, March 19th. Zacks Research analyst R. Department now ...

We recently compiled a list of the 10 Best Entertainment. In this article, we are going to take a look at where Flutter ...

Tuesday, STAAR Surgical Company (NASDAQ:STAA), currently trading at $17.61 and down over 54% in the past year, maintained its Neutral rating by BTIG, as the company announced several executive ...

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

Detailed price information for Adaptive Biotechnologies Corp (ADPT-Q) from The Globe and Mail including charting and trades.

The tariffs are hitting during what is typically the busiest time of year for home sales. The prospect of a trade war and ...